ISRCTN ISRCTN61185493
DOI https://doi.org/10.1186/ISRCTN61185493
Protocol serial number NIH AT001901
Sponsor National Institutes of Health, National Center for Complementary and Alternative Medicine (USA)
Funder National Institutes of Health (ref: NCCAM AT001901)
Submission date
06/08/2007
Registration date
29/08/2007
Last edited
17/05/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Neonatal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Kathi Kemper
Scientific

Wake Forest University School of Medicine
Medical Center Blvd.
Winston-Salem
27157
United States of America

Study information

Primary study designInterventional
Study designRandomized controlled trial.
Secondary study designRandomised controlled trial
Scientific titleHarp music: Effects on heart rate variability, cortisol and activity
Study objectivesThe null hypothesis is that harp music has no effect compared with usual care or a quiet room on any parameter of heart rate variability, salivary cortisol or activity of premature infants.
Ethics approval(s)Approved by Wake Forest University School of Medicine (WFUSM) Institutional Review Board on 03/31/2005 (Protocol no. BG05-162)
Health condition(s) or problem(s) studiedPrematurity
InterventionHarp music vs quiet room. The infants allocated to the intervention group had harp music for 45 minutes each day for 3 days.
Intervention typeOther
Primary outcome measure(s)1. Salivary cortisol was measured just prior to harp music/quiet/usual care observation period and just after each day
2. HRV was measured during the intervention each day
3. Activity was measured during and after the intervention each day
4. Weight, meausred at baseline (Monday) and 5 days (Friday)
Key secondary outcome measure(s)Growth, measured as weight gain at 5 days (this trial is 5 days long).
Completion date30/12/2006

Eligibility

Participant type(s)Patient
Age groupNeonate
SexAll
Target sample size at registration90
Total final enrolment8
Key inclusion criteriaInfants hospitalized at Brenner Children's Hospital Neonatal Intensive Care or Intermediate Care UnitsInfants were eligible if they satisfied the following criteria:
1. Born between 25 and 36 weeks gestational age
2. At least 34 weeks gestational age by the time of enrollment
3. Had been medically stable in the intermediate care nursery for at least three days
4. Had passed the neonatal hearing screen
5. Slept in a crib rather than an isolette
6. Took full oral feedings
7. Free of apnea and bradycardia spells
8. Expected to remain in the intermediate nursery for at least seven more days to achieve stable body temperature
Key exclusion criteria1. Any medical condition known to adversely affect either:
1.1. Central nervous system (e.g. intraventricular hemorrhage of Grade II or higher)
1.2. Cardiac or adrenal function (e.g. major cardiac anomaly)
1.3. Movement (e.g. spasticity, hypotonia, or fractured clavicle)
2. Any ongoing need for stressful or invasive medical procedures or steroid medications
Date of first enrolment01/04/2005
Date of final enrolment30/12/2006

Locations

Countries of recruitment

  • United States of America

Study participating centre

Wake Forest University School of Medicine
Winston-Salem
27157
United States of America

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summary
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/12/2008 17/05/2019 Yes No

Editorial Notes

17/05/2019: Publication reference and total final enrolment added.